Halozyme Therapeutics
HALO
#2445
Rank
A$10.99 B
Marketcap
A$93.48
Share price
0.50%
Change (1 day)
24.60%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: A$10.99 Billion

As of December 2025 Halozyme Therapeutics has a market cap of A$10.99 Billion. This makes Halozyme Therapeutics the world's 2445th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025A$10.99 B11.67%
2024A$9.84 B37.38%
2023A$7.16 B-36.61%
2022A$11.30 B44.79%
2021A$7.80 B3.99%
2020A$7.50 B116.89%
2019A$3.46 B15.19%
2018A$3.00 B-18.64%
2017A$3.69 B108.15%
2016A$1.77 B-41.78%
2015A$3.04 B105.65%
2014A$1.48 B-22.98%
2013A$1.92 B164.48%
2012A$0.72 B-24.33%
2011A$0.96 B22.63%
2010A$0.78 B30.9%
2009A$0.59 B-7.33%
2008A$0.64 B2.04%
2007A$0.63 B-9.74%
2006A$0.70 B368.4%
2005A$0.14 B7.13%
2004A$0.13 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Halozyme Therapeutics was reported to be:

A$10.99 Billion
by Nasdaq info icon info icon
A$10.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MannKind Corp
MNKD
A$2.74 B-75.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.384 T 12,490.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$14.79 B 34.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$220.86 B 1,909.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$178.55 B 1,524.23%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
A$766.01 B 6,868.00%๐Ÿ‡บ๐Ÿ‡ธ USA